Tag: seelos therapeutics

December 4, 2019

Seelos Therapeutics Gets Notice of Allowance for Another US Patent for SLS-005

The company announced that it has received a notice of allowance from the US Patent and Trademark Office for patent...
November 27, 2019

Seelos Therapeutics Begins Dosing in Phase 1 PK/KD Study

The company said it expects to announce preliminary data from the Phase 1 cllinical trial in the first quarter of...
August 22, 2019

Seelos Therapeutics Receives IND Application Approval for SLS-005

Seelos Therapeutics (NASDAQ:SEEL) has announced that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug Application...
July 17, 2019

Seelos Therapeutics Submits Investigational New Drug Application for SLS-005

Seelos Therapeutics (NASDAQ:SEEL) has announced it has submitted an investigational new drug application to the US Food and Drug Administration...
March 7, 2019

Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents

Seelos Therapeutics (NASDAQ:SEEL) has announced it has acquired an exclusive license to intellectual property owned by the Regents of the...
January 25, 2019

Ligand Partner Seelos Therapeutics Becomes a Public Company

Ligand Pharmaceuticals (NASDAQ:LGND) partner Seelos Therapeutics (NASDAQ:SEEL) announced that it has closed a reverse merger with Apricus Biosciences. As quoted in...
January 24, 2019

Seelos Therapeutics Announces Successful Completion of its Merger with Apricus Biosciences

Seelos Therapeutics (Nasdaq:SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical...